These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 27181225)
41. Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles. Chu J; Lauretti E; Craige CP; Praticò D J Alzheimers Dis; 2014; 41(3):729-37. PubMed ID: 24662099 [TBL] [Abstract][Full Text] [Related]
42. The blockage of the Nogo/NgR signal pathway in microglia alleviates the formation of Aβ plaques and tau phosphorylation in APP/PS1 transgenic mice. Fang Y; Yao L; Li C; Wang J; Wang J; Chen S; Zhou XF; Liao H J Neuroinflammation; 2016 Mar; 13(1):56. PubMed ID: 26939570 [TBL] [Abstract][Full Text] [Related]
43. Impact of the cellular prion protein on amyloid-β and 3PO-tau processing. Schmitz M; Wulf K; Signore SC; Schulz-Schaeffer WJ; Kermer P; Bähr M; Wouters FS; Zafar S; Zerr I J Alzheimers Dis; 2014; 38(3):551-65. PubMed ID: 24028865 [TBL] [Abstract][Full Text] [Related]
45. Local factor H production by human choroidal endothelial cells mitigates complement deposition: implications for macular degeneration. Mulfaul K; Mullin NK; Giacalone JC; Voigt AP; R DeVore M; Stone EM; Tucker BA; Mullins RF J Pathol; 2022 May; 257(1):29-38. PubMed ID: 35038170 [TBL] [Abstract][Full Text] [Related]
46. The potential role of amyloid beta in the pathogenesis of age-related macular degeneration. Yoshida T; Ohno-Matsui K; Ichinose S; Sato T; Iwata N; Saido TC; Hisatomi T; Mochizuki M; Morita I J Clin Invest; 2005 Oct; 115(10):2793-800. PubMed ID: 16167083 [TBL] [Abstract][Full Text] [Related]
47. Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium. Schwesinger C; Yee C; Rohan RM; Joussen AM; Fernandez A; Meyer TN; Poulaki V; Ma JJ; Redmond TM; Liu S; Adamis AP; D'Amato RJ Am J Pathol; 2001 Mar; 158(3):1161-72. PubMed ID: 11238064 [TBL] [Abstract][Full Text] [Related]
48. Hypercholesterolemia accelerates intraneuronal accumulation of Aβ oligomers resulting in memory impairment in Alzheimer's disease model mice. Umeda T; Tomiyama T; Kitajima E; Idomoto T; Nomura S; Lambert MP; Klein WL; Mori H Life Sci; 2012 Dec; 91(23-24):1169-76. PubMed ID: 22273754 [TBL] [Abstract][Full Text] [Related]
49. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease. Howlett DR; Bowler K; Soden PE; Riddell D; Davis JB; Richardson JC; Burbidge SA; Gonzalez MI; Irving EA; Lawman A; Miglio G; Dawson EL; Howlett ER; Hussain I Histol Histopathol; 2008 Jan; 23(1):67-76. PubMed ID: 17952859 [TBL] [Abstract][Full Text] [Related]
50. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708 [TBL] [Abstract][Full Text] [Related]
51. Altered function of factor I caused by amyloid beta: implication for pathogenesis of age-related macular degeneration from Drusen. Wang J; Ohno-Matsui K; Yoshida T; Kojima A; Shimada N; Nakahama K; Safranova O; Iwata N; Saido TC; Mochizuki M; Morita I J Immunol; 2008 Jul; 181(1):712-20. PubMed ID: 18566438 [TBL] [Abstract][Full Text] [Related]
52. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110 [TBL] [Abstract][Full Text] [Related]
53. Co-localization of beta-peptide and phosphorylated tau in astrocytes in a patient with corticobasal degeneration. Wakabayashi K; Mori F; Hasegawa M; Kusumi T; Yoshimura I; Takahashi H; Kaneko S Neuropathology; 2006 Feb; 26(1):66-71. PubMed ID: 16521482 [TBL] [Abstract][Full Text] [Related]
54. Suppressed retinal degeneration in aged wild type and APPswe/PS1ΔE9 mice by bone marrow transplantation. Yang Y; Shiao C; Hemingway JF; Jorstad NL; Shalloway BR; Chang R; Keene CD PLoS One; 2013; 8(6):e64246. PubMed ID: 23750207 [TBL] [Abstract][Full Text] [Related]
55. Watching synchronous mitochondrial respiration in the retina and its instability in a mouse model of macular degeneration. Kaynezhad P; Tachtsidis I; Aboelnour A; Sivaprasad S; Jeffery G Sci Rep; 2021 Feb; 11(1):3274. PubMed ID: 33558624 [TBL] [Abstract][Full Text] [Related]
56. Retinal changes precede visual dysfunction in the complement factor H knockout mouse. Williams JA; Greenwood J; Moss SE PLoS One; 2013; 8(7):e68616. PubMed ID: 23844226 [TBL] [Abstract][Full Text] [Related]
57. Complement factor H: spatial and temporal expression and localization in the eye. Mandal MN; Ayyagari R Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4091-7. PubMed ID: 16936129 [TBL] [Abstract][Full Text] [Related]
58. Complement Factor H Mutation W1206R Causes Retinal Thrombosis and Ischemic Retinopathy in Mice. Song D; Ueda Y; Bhuyan R; Mohammed I; Miwa T; Gullipali D; Kim H; Zhou L; Song Y; Schultz H; Bargoud A; Dunaief JL; Song WC Am J Pathol; 2019 Apr; 189(4):826-838. PubMed ID: 30711487 [TBL] [Abstract][Full Text] [Related]
59. Primate retinal cones express phosphorylated tau associated with neuronal degeneration yet survive in old age. Aboelnour A; Van der Spuy J; Powner M; Jeffery G Exp Eye Res; 2017 Dec; 165():105-108. PubMed ID: 28974357 [TBL] [Abstract][Full Text] [Related]
60. Dementia of the eye: the role of amyloid beta in retinal degeneration. Ratnayaka JA; Serpell LC; Lotery AJ Eye (Lond); 2015 Aug; 29(8):1013-26. PubMed ID: 26088679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]